Choline as a biomarker for cell proliferation: Do the results from proton MR spectroscopy show difference between HER2/neu positive and negative breast cancers?-Reference-Cited by-同舟云学术

Choline as a biomarker for cell proliferation: Do the results from proton MR spectroscopy show difference between HER2/neu positive and negative breast cancers?

Published:2008-09-01 Issue:5 Volume:123 Page:1219-1221
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Baek Hyeon‐Man,Chen Jeon‐Hor,Nalcioglu Orhan,Su Min‐Ying

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference20 articles.

1. Radiation Oncology Investigations 10657541 15206823 1999 7 6

2. The distinctive nature of HER2‐positive breast cancers;Burstein;N Engl J Med,2005

3. Prospect for anti‐her2 receptor therapy in breast cancer;Brand;Anticancer Res,2006

4. Role of HER2/neu in tumor progression and therapy;Ménard;Cell Mol Life Sci,2004

5. Biology of HER2 and its importance in breast cancer;Yarden;Oncology,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insular Cell Integrity Markers Linked to Weight Concern in Anorexia Nervosa—An MR-Spectroscopy Study;Journal of Clinical Medicine;2020-04-30

2. Patrones de captación en las glándulas suprarrenales de la PET/TC con 18F-Fluoroetilcolina;Revista Española de Medicina Nuclear e Imagen Molecular;2020-03

3. Adrenal glands uptake patterns in 18F-Fluoroethylcholine PET/CT;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2020-03

4. Defining a metabolic landscape of tumours: genome meets metabolism;British Journal of Cancer;2019-12-10

5. Breast Magnetic Resonance Spectroscopy at 3 T in Biopsy-Proven Breast Cancers;Investigative Radiology;2019-12